BioCentury
ARTICLE | Financial News

Collegium raises $50M <span class="*Red-type+bold">

March 11, 2015 1:34 AM UTC

Collegium Pharmaceutical Inc. (Canton, Mass.) raised $50 million in a series D round led by new investor TPG Biotech. New investors RA Capital, Adage Capital, Rock Springs Capital, EcoR1 Capital, Eventide Asset Management and Aperture Venture Partners participated, as did existing investors Longitude Capital, Skyline Ventures, Frazier Healthcare and Boston Millennia Partners. ...